{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T13:19:59Z","timestamp":1785590399017,"version":"3.56.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:00:00Z","timestamp":1436400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0132028","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T17:52:59Z","timestamp":1436464379000},"page":"e0132028","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume"],"prefix":"10.1371","volume":"10","author":[{"given":"Ayush","family":"Giri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd L.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saundra S.","family":"Motley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan H.","family":"Byerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Fowke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mcna.2010.08.013","article-title":"Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)","volume":"95","author":"CG Roehrborn","year":"2011","journal-title":"Med Clin North Am"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.ju.0000155709.37840.fe","article-title":"Urologic diseases in America project: benign prostatic hyperplasia","volume":"173","author":"JT Wei","year":"2005","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.eururo.2006.05.040","article-title":"The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia","volume":"51","author":"C Ozden","year":"2007","journal-title":"Eur Urol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.urology.2006.09.034","article-title":"Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans","volume":"68","author":"A Gupta","year":"2006","journal-title":"Urology"},{"key":"ref5","first-page":"2562","article-title":"Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab","volume":"91","author":"JK Parsons","year":"2006","journal-title":"Endocrine Society"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.juro.2009.07.086","article-title":"Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions","volume":"182","author":"JK Parsons","year":"2009","journal-title":"J Urol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11884-010-0067-2","article-title":"Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors","volume":"5","author":"JK Parsons","year":"2010","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.pcan.4500924","article-title":"The association between body size, prostate volume and prostate-specific antigen","volume":"10","author":"JH Fowke","year":"2007","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/aje\/kwg051","article-title":"Risk Factors for Lower Urinary Tract Symptoms in a Population-based Sample of African-American Men","volume":"157","author":"MA Joseph","year":"2003","journal-title":"Am J Epidemiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1464-410X.2005.05573.x","article-title":"The prevalence and correlates of urinary tract symptoms in Norwegian men: the HUNT study","volume":"96","author":"A Seim","year":"2005","journal-title":"BJU Int"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/aje\/kwh060","article-title":"Associations of Obesity with Lower Urinary Tract Symptoms and Noncancer Prostate Surgery in the Third National Health and Nutrition Examination Survey","volume":"159","author":"S Rohrmann","year":"2004","journal-title":"Am J Epidemiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.juro.2006.11.065","article-title":"Race\/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial","volume":"177","author":"AR Kristal","year":"2007","journal-title":"J Urol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0022-5347(05)64687-3","article-title":"Body Size And Serum Levels of Insulin and Leptin in Relation to the Risk of Benign Prostatic Hyperplasia","volume":"168","author":"SE Dahle","year":"2002","journal-title":"J Urol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/oxfordjournals.aje.a117206","article-title":"Obesity and Benign Prostatic Hyperplasia","volume":"140","author":"E Giovannucci","year":"1994","journal-title":"Am J Epidemiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.eururo.2013.02.038","article-title":"Obesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasteride","volume":"63","author":"RL Muller","year":"2013","journal-title":"Eur Urol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1464-410X.2007.07332.x","article-title":"Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men","volume":"101","author":"JK Parsons","year":"2008","journal-title":"BJU Int"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.juro.2009.07.088","article-title":"Diabetes and benign prostatic hyperplasia\/lower urinary tract symptoms\u2014what do we know?","volume":"182","author":"A V Sarma","year":"2009","journal-title":"J Urol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.juro.2007.03.103","article-title":"Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems","volume":"178","author":"JK Parsons","year":"2007","journal-title":"J Urol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cca.2006.01.019","article-title":"Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia","volume":"370","author":"H Nandeesha","year":"2006","journal-title":"Clin Chim Acta"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ucl.2007.09.012","article-title":"Inflammation and benign prostatic hyperplasia","volume":"35","author":"JC Nickel","year":"2008","journal-title":"Urol Clin North Am"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/pros.20110","article-title":"Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"62","author":"S Rohrmann","year":"2005","journal-title":"Prostate"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/aje\/kwp085","article-title":"Associations between C-reactive protein and benign prostatic hyperplasia\/lower urinary tract symptom outcomes in a population-based cohort","volume":"169","author":"JL St Sauver","year":"2009","journal-title":"Am J Epidemiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0302-2838(02)00548-1","article-title":"Distribution of Inflammation, Pre-Malignant Lesions, Incidental Carcinoma in Histologically Confirmed Benign Prostatic Hyperplasia: A Retrospective Analysis","volume":"43","author":"F Di Silverio","year":"2003","journal-title":"Eur Urol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/aje\/kwp406","article-title":"Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial","volume":"171","author":"JM Schenk","year":"2010","journal-title":"Am J Epidemiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.juro.2009.06.038","article-title":"Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia","volume":"182","author":"JK Parsons","year":"2009","journal-title":"J Urol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.eururo.2008.02.019","article-title":"Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms","volume":"53","author":"JK Parsons","year":"2008","journal-title":"Eur Urol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0090-4295(94)80197-5","article-title":"Concordance rates for benign prostatic disease among twins suggest hereditary influence","volume":"44","author":"AW Martin","year":"1994","journal-title":"Urology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.urolonc.2004.12.014","article-title":"Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer","volume":"23","author":"MT Salam","year":"2005","journal-title":"Urol Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/pros.20142","article-title":"Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH","volume":"62","author":"RO Roberts","year":"2005","journal-title":"Prostate"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/pros.21092","article-title":"Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial","volume":"70","author":"AR Kristal","year":"2010","journal-title":"Prostate"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-002-0776-5","article-title":"Androgen receptor CAG polymorphism and prostate cancer risk","volume":"111","author":"N Mononen","year":"2002","journal-title":"Hum Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/pros.22666","article-title":"Genetic variants in 2q31 and 5p15 are associated with aggressive benign prostatic hyperplasia in a Chinese population","volume":"73","author":"J Qi","year":"2013","journal-title":"Prostate"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e1002793","DOI":"10.1371\/journal.pgen.1002793","article-title":"The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits","volume":"8","author":"BF Voight","year":"2012","journal-title":"PLoS Genet"},{"issue":"Suppl 3","key":"ref34","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/ijir.2008.53","article-title":"The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia","volume":"20","author":"CG Roehrborn","year":"2008","journal-title":"Int J Impot Res"},{"key":"ref35","first-page":"73","article-title":"Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12\u201313, 1993","volume":"162","author":"TA Stamey","year":"1994","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"S Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1158\/1055-9965.EPI-13-0123","article-title":"Pleiotropy between genetic markers of obesity and risk of prostate cancer","volume":"22","author":"TL Edwards","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/gepi.20310","article-title":"A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms","volume":"32","author":"X Gao","year":"2008","journal-title":"Genet Epidemiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ng.686","article-title":"Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index","volume":"42","author":"EK Speliotes","year":"2010","journal-title":"Nat Genet"},{"key":"ref40","first-page":"949","article-title":"Nat Genet","volume":"42","author":"IM Heid","year":"2010"},{"key":"ref41","first-page":"832","article-title":"Nature","volume":"467","author":"H Lango Allen","year":"2010"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gkr917","article-title":"HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants","volume":"40","author":"LD Ward","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/gb-2012-13-9-r51","article-title":"The GENCODE pseudogene resource","volume":"13","author":"B Pei","year":"2012","journal-title":"Genome Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/bioinformatics\/14.8.656","article-title":"GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support","volume":"14","author":"M Rebhan","year":"1998","journal-title":"Bioinformatics"},{"key":"ref45","first-page":"e51954","article-title":"Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One","volume":"7","author":"AG Comuzzie","year":"2012","journal-title":"Public Library of Science"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccr.2013.08.020","article-title":"Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target","volume":"24","author":"LA Timmerman","year":"2013","journal-title":"Cancer Cell"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1124\/jpet.109.162248","article-title":"Pharmacogenomic approach reveals a role for the x(c)- cystine\/glutamate antiporter in growth and celastrol resistance of glioma cell lines","volume":"332","author":"A-N Pham","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/sj.bjc.6604485","article-title":"The xc- cystine\/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance","volume":"99","author":"M Lo","year":"2008","journal-title":"Br J Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1423-0127-18-45","article-title":"Stromal upregulation of lateral epithelial adhesions: gene expression analysis of signalling pathways in prostate epithelium","volume":"18","author":"KF Chambers","year":"2011","journal-title":"J Biomed Sci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2007.09.018","article-title":"Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells","volume":"259","author":"AP Singh","year":"2008","journal-title":"Cancer Lett"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e1000539","DOI":"10.1371\/journal.pgen.1000539","article-title":"NRXN3 is a novel locus for waist circumference: a genome-wide association study from the CHARGE Consortium","volume":"5","author":"NL Heard-Costa","year":"2009","journal-title":"PLoS Genet. Public Library of Science"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ng.2606","article-title":"Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture","volume":"45","author":"SI Berndt","year":"2013","journal-title":"Nat Genet"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1432-0436.2008.00274.x","article-title":"Gene expression profiling in the developing prostate","volume":"76","author":"CC Pritchard","year":"2008","journal-title":"Differentiation"},{"key":"ref54","unstructured":"Guyon I. Biomarkers for screening, predicting, and monitoring prostate disease. U.S. Patent Application; 11\/214,931, 2005."},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0022-5347(01)66779-X","article-title":"Transition Zone Index as a Method of Assessing Benign Prostatic Hyperplasia: Correlation with Symptoms, Urine Flow and Detrusor Pressure","volume":"154","author":"SA Kaplan","year":"1995","journal-title":"J Urol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11606-011-1776-8","article-title":"Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men","volume":"26","author":"JH Fowke","year":"2011","journal-title":"J Gen Intern Med"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-5347(05)67909-8","article-title":"Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study","volume":"163","author":"EA Platz","year":"2000","journal-title":"J Urol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0090-4295(03)00154-7","article-title":"Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men\u2019s Health Study","volume":"61","author":"V Sarma A","year":"2003","journal-title":"Urology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2407-12-23","article-title":"Obesity, body composition, and prostate cancer","volume":"12","author":"JH Fowke","year":"2012","journal-title":"BMC Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0132028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T21:15:28Z","timestamp":1599254128000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0132028"}},"subtitle":[],"editor":[{"given":"Zoran","family":"Culig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,9]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0132028","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,9]]}}}